Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes

Int J Cardiol. 2011 Sep 15;151(3):385-7. doi: 10.1016/j.ijcard.2011.06.117. Epub 2011 Jul 22.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome / blood*
  • Acute Coronary Syndrome / drug therapy*
  • Acute Coronary Syndrome / pathology
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Blood Platelets / drug effects
  • Blood Platelets / pathology*
  • Eptifibatide
  • Female
  • Humans
  • Inflammation Mediators / blood*
  • Male
  • Middle Aged
  • Peptides / pharmacology
  • Peptides / therapeutic use*
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Prospective Studies

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Inflammation Mediators
  • Peptides
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Eptifibatide